GlassScriptPhysician profile
Della L Howell
NPI 1457383994
$1,333.42
in general payments reported to CMS, 2019-2025
20 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Pediatric Hematology-Oncology provider received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $334 · 2023: $378 · 2024: $282 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $999.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $398.40 | 2022-2025 | |
| Servier Pharmaceuticals LLC | $124.99 | 2025 | |
| Sobi, INC | $122.07 | 2022 | |
| Uswm, LLC | $113.30 | 2024-2025 | Iwilfin |
| Pharming Healthcare, INC. | $65.82 | 2022-2023 | Ruconest |
| Takeda Pharmaceuticals U.S.A., INC. | $63.04 | 2023 | Advate, Gattex |
| Pfizer INC. | $62.12 | 2023 | |
| Nestle Healthcare Nutrition INC. | $52.87 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $41.66 | 2023-2024 | |
| Alexion Pharmaceuticals, INC. | $37.85 | 2022-2024 | Ultomiris |
| Mirum Pharmaceuticals, INC. | $35.51 | 2022-2023 | Livmarli |
| Acadia Pharmaceuticals INC | $32.48 | 2024 | Daybue |
| Bayer Healthcare Pharmaceuticals INC. | $28.57 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $28.14 | 2023 | Kristalose |
| Ptc Therapeutics, INC. | $24.17 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $23.42 | 2022 | |
| Day One Biopharmaceuticals | $22.33 | 2024 | Ojemda |
| Alcresta Therapeutics, INC. | $21.11 | 2023 | Relizorb |
| Pharmacyclics LLC, An Abbvie Company | $18.65 | 2022 | |
| Global Blood Therapeutics, INC. | $16.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Della Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.